Want to see JP:4369 full AI Analyst Report?
Top Page
Tri Chemical Laboratories Inc.
(4369)
Select Model
Select Model
Rating:62Neutral
Price Target:
¥3,631.00
▲(33.99% Upside)
Action:Downgraded
Date:09/06/26
The score is primarily supported by strong profitability and a conservatively financed balance sheet, but is held back by weak free-cash-flow conversion and bearish technical trends (price below major moving averages and negative MACD). Valuation is reasonable on earnings, though the dividend yield is modest.
Positive Factors
Strong Profitability
High gross, operating, and net margins indicate that Tri Chemical Laboratories converts revenue into substantial operating and shareholder returns. The stated pricing power and cost control provide a durable earnings base and can support reinvestment even as specialty-chemical market conditions vary.
Negative Factors
Weak Free Cash Flow
Free cash flow is materially weaker than reported earnings, indicating that substantial reinvestment or working-capital requirements are absorbing cash. This lowers financial flexibility, may constrain internally funded growth, and makes earnings quality less dependable despite strong accounting profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Profitability
High gross, operating, and net margins indicate that Tri Chemical Laboratories converts revenue into substantial operating and shareholder returns. The stated pricing power and cost control provide a durable earnings base and can support reinvestment even as specialty-chemical market conditions vary.
Read all positive factors
Tri Chemical Laboratories Inc. (4369) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥95.93B
Dividend Yield1.19%
Average Volume (3M)420.85K
Price to Earnings (P/E)15.7
Beta (1Y)1.31
Revenue Growth12.47%
EPS Growth7.08%
CountryJP
Employees313
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)188.07
Shares Outstanding32,498,640
10 Day Avg. Volume400,100
30 Day Avg. Volume420,850
Financial Highlights & Ratios
PEG Ratio1.74
Price to Book (P/B)2.97
Price to Sales (P/S)4.49
P/FCF Ratio-43.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥4,000.00Price Target Upside47.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)194.66
Revenue Forecast (FY)¥29.75B
Tri Chemical Laboratories Inc. Business Overview & Revenue Model
Company Description
Founded in 1978 and headquartered in Uenohara, Japan, Tri Chemical Laboratories Inc. develops and supplies essential chemical compounds for cutting-edge industries. The company provides crucial precursors for the production of semiconductors, opti...
Tri Chemical Laboratories Inc. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
52
Neutral
| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.21B | 23.88B | 18.91B | 11.25B | 13.80B | 11.57B |
| Gross Profit | 9.63B | 9.02B | 7.95B | 4.02B | 5.51B | 4.77B |
| EBITDA | 8.84B | 7.82B | 6.63B | 3.25B | 4.71B | 4.00B |
| Net Income | 6.11B | 5.52B | 4.96B | 2.47B | 4.83B | 4.10B |
Balance Sheet | ||||||
| Total Assets | 49.12B | 47.27B | 37.13B | 31.86B | 32.12B | 28.44B |
| Cash, Cash Equivalents and Short-Term Investments | 10.08B | 7.28B | 9.44B | 10.50B | 11.14B | 8.03B |
| Total Debt | 6.05B | 4.13B | 1.78B | 2.40B | 3.24B | 4.28B |
| Total Liabilities | 10.87B | 11.13B | 5.54B | 4.29B | 6.24B | 7.12B |
| Stockholders Equity | 38.25B | 36.15B | 31.59B | 27.57B | 25.88B | 21.32B |
Cash Flow | ||||||
| Free Cash Flow | 197.73M | -2.49B | 605.75M | 1.23B | 4.86B | 2.76B |
| Operating Cash Flow | 5.94B | 3.80B | 3.68B | 2.97B | 6.39B | 3.64B |
| Investing Cash Flow | -6.48B | -7.05B | -3.12B | -1.78B | -1.56B | -932.88M |
| Financing Cash Flow | 3.47B | 1.09B | -1.62B | -1.86B | -1.70B | 3.59B |
Tri Chemical Laboratories Inc. Technical Analysis
Negative
2710.00
Price Trends
3160.60
Negative
3337.01
Negative
3260.51
Negative
Market Momentum
-24.59
Positive
40.91
Neutral
16.72
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4369, the sentiment is Negative. The current price of 2710 is below the 20-day moving average (MA) of 3207.30, below the 50-day MA of 3160.60, and below the 200-day MA of 3260.51, indicating a bearish trend. The MACD of -24.59 indicates Positive momentum. The RSI at 40.91 is Neutral, neither overbought nor oversold. The STOCH value of 16.72 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4369.
Tri Chemical Laboratories Inc. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥143.72B | 12.67 | 7.28% | 7.48% | -0.03% | 5.43% | |
77 Outperform | ¥97.69B | 10.69 | ― | 2.54% | 3.44% | 15.09% | |
75 Outperform | ¥93.44B | 9.52 | ― | 4.07% | 4.74% | 124.50% | |
74 Outperform | ¥94.45B | 10.48 | ― | 3.92% | 1.64% | -24.06% | |
70 Outperform | ¥96.15B | 10.06 | 16.64% | 1.91% | 17.54% | 90.80% | |
62 Neutral | ¥95.93B | 15.70 | ― | 1.19% | 12.47% | 7.08% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
JP:4369
Tri Chemical Laboratories Inc.
2,897.00
-13.41
-0.46%
JP:4471
Sanyo Chemical Industries
1,619.00
575.66
55.18%
JP:4187
Osaka Organic Chemical Industry Ltd.
4,270.00
511.86
13.62%
JP:4008
Sumitomo Seika Chemicals Co., Ltd.
1,445.00
507.72
54.17%
JP:4116
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
1,303.00
340.30
35.35%
JP:4956
Konishi Co., Ltd.
1,495.00
206.58
16.03%
Tri Chemical Laboratories Inc. Corporate Events
Tri Chemical Laboratories Lifts Full-Year Outlook on Strong Semiannual Earnings
Aug 31, 2026
Tri Chemical Laboratories Inc. reported robust semiannual results for the six months ended July 31, 2026, with net sales rising 18.8% year on year to ¥14.7 billion and profit attributable to owners of parent climbing 21.5% to ¥3.37 billi...
Tri Chemical Laboratories Hikes Full-Year Outlook on AI-Driven Chip Demand
Aug 31, 2026
Tri Chemical Laboratories reported that its first-half results to July 31, 2026 significantly exceeded earlier forecasts, with net sales rising 7.3% and profit attributable to owners of parent jumping 54.0%. The outperformance was driven by strong...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.